MARKET

ENDP

ENDP

Endo Intl
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.135
+0.025
+0.61%
Closed 19:24 11/12 EST
OPEN
4.120
PREV CLOSE
4.110
HIGH
4.220
LOW
3.980
VOLUME
5.53M
TURNOVER
--
52 WEEK HIGH
13.75
52 WEEK LOW
1.970
MARKET CAP
937.72M
P/E (TTM)
-2.2589
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ENDP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 14 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ENDP News

  • Miller Value Partners Deep Value Strategies Q3 2019 Letter
  • Seeking Alpha - Article.1d ago
  • Edited Transcript of ENDP earnings conference call or presentation 5-Nov-19 12:30pm GMT
  • Thomson Reuters StreetEvents.4d ago
  • Endo CEO to step down when successor is named
  • MarketWatch.6d ago
  • Endo begins search for a new CEO
  • American City Business Journals.11/05 20:56

More

Industry

Pharmaceuticals
+0.28%
Pharmaceuticals & Medical Research
+0.31%

Hot Stocks

Name
Price
%Change

About ENDP

Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.
More

Webull offers Endo International PLC (ENDP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.